-
The FDA has given an accelerated approval for a new protease inhibitor (PI) for the treatment of HIV infections. Darunavir (TMC114) is approved for patients who have shown resistance to more than one protease inhibitor.
-
The two non-sequential lead II rhythm strips shown in the image were interpreted as showing "sinus tachycardia (top strip) with sudden development of PSVT" (lower strip).
-
Cephalosporins should be considered for penicillin-allergic patients due to low cross-reactivity risk, but these patients do have a small increased risk of subsequent reactions to both sulfonamides and cephalosporins.
-
Black cohosh, when studied in appropriate randomized trials, is no different than placebo treatment in affecting hot flushing.
-
Borrelia persica is the causative agent of tick-borne relapsing fever (TBRF). The Borrelia name will be familiar to clinicians because of Lyme disease, caused by Borrelia burgdorferi.
-
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.
-
The Food and Drug Administration (FDA) has just given approval to Seasonique (Duramed Pharmaceuticals; Pomona, NY), an extended-regimen oral contraceptive (OC).
-
Women who switch to the NuvaRing contraceptive vaginal ring (Organon, Roseland, NJ) from other forms of hormonal contraception experience reduced hormone-related adverse events, according to results from a study presented at the recent European Society of Contraception in Istanbul, Turkey.1
-
Your next patient is a 35-year-old mother of two who is experiencing ongoing heavy menstrual bleeding (menorrhagia). Recently remarried, she says she may want to have a child in the future with her new partner. What are your treatment options?
